Cargando…

Engineered reporter phages for detection of Escherichia coli, Enterococcus, and Klebsiella in urine

The rapid detection and species-level differentiation of bacterial pathogens facilitates antibiotic stewardship and improves disease management. Here, we develop a rapid bacteriophage-based diagnostic assay to detect the most prevalent pathogens causing urinary tract infections: Escherichia coli, En...

Descripción completa

Detalles Bibliográficos
Autores principales: Meile, Susanne, Du, Jiemin, Staubli, Samuel, Grossmann, Sebastian, Koliwer-Brandl, Hendrik, Piffaretti, Pietro, Leitner, Lorenz, Matter, Cassandra I., Baggenstos, Jasmin, Hunold, Laura, Milek, Sonja, Guebeli, Christian, Kozomara-Hocke, Marko, Neumeier, Vera, Botteon, Angela, Klumpp, Jochen, Marschall, Jonas, McCallin, Shawna, Zbinden, Reinhard, Kessler, Thomas M., Loessner, Martin J., Dunne, Matthew, Kilcher, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359277/
https://www.ncbi.nlm.nih.gov/pubmed/37474554
http://dx.doi.org/10.1038/s41467-023-39863-x
Descripción
Sumario:The rapid detection and species-level differentiation of bacterial pathogens facilitates antibiotic stewardship and improves disease management. Here, we develop a rapid bacteriophage-based diagnostic assay to detect the most prevalent pathogens causing urinary tract infections: Escherichia coli, Enterococcus spp., and Klebsiella spp. For each uropathogen, two virulent phages were genetically engineered to express a nanoluciferase reporter gene upon host infection. Using 206 patient urine samples, reporter phage-induced bioluminescence was quantified to identify bacteriuria and the assay was benchmarked against conventional urinalysis. Overall, E. coli, Enterococcus spp., and Klebsiella spp. were each detected with high sensitivity (68%, 78%, 87%), specificity (99%, 99%, 99%), and accuracy (90%, 94%, 98%) at a resolution of ≥10(3) CFU/ml within 5 h. We further demonstrate how bioluminescence in urine can be used to predict phage antibacterial activity, demonstrating the future potential of reporter phages as companion diagnostics that guide patient-phage matching prior to therapeutic phage application.